Methyl 5-fluoro-4-hydroxy-2-nitrobenzoate, 98%, 1g

2-Methoxy-5-nitrobenzoic acid, 95.0%, 25g

Palladium(II) nitrate dihydrate, 40% Pd., 1 g, glass packaging

2,6-DIBROMOPYRIDIN-4-YLBORONIC ACID, 97.0%, 5g

4-Bromo-5-methylpyridin-2-amine, 95.0%, 5g

1-(4-Fluorophenyl)piperidin-4-one, 95.0%, 1g

3-Bromobicyclo[1.1.1]pentane-1-carbonitrile, 97%, 100mg

Trial kit Spectra/Por® 1-3 Spectra/Por® 1 – MWCO 6000–8000, 50 mm, 1 Piece(s)

3-(Benzylamino)-N-hydroxy-4-methylbenzamide, 98%, 50mg

5-(5-ethyl-3-thienyl)-4-methyl-4H-1,2,4-triazole-3-thiol, 95.0%, 1g

Methyl 2-fluoro-4-formylbenzoate, 95.0%, 10g

4-bromo-N-cyclopentyl-2-fluorobenzenesulfonamide, 95.0%, 1g

((1S,2S,5R)-2-Isopropyl-5-methylcyclohexyl)diphenylphosphine, 95.0%, 100mg